Trans American Aquaculture (GRPS) Shares Outstanding (Weighted Average) (2022 - 2025)
Trans American Aquaculture (GRPS) reported Shares Outstanding (Weighted Average) of $1.8 billion for Q3 2025, up 22.69% on a YoY basis from $1.5 billion in Q3 2024, and little changed quarter-over-quarter from $1.8 billion in Q2 2025.
Trans American Aquaculture (GRPS) Shares Outstanding (Weighted Average) (2022 - 2025) Analysis & Trends
Trans American Aquaculture has reported Shares Outstanding (Weighted Average) for 4 years, with the latest figure at $1.8 billion in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 22.69% year-over-year to $1.8 billion; the trailing twelve-month figure through Sep 2025 stood at $1.8 billion (up 22.69% YoY), and the FY2024 full-year result was $1.8 billion, up 24.36% from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 stood at $1.8 billion, roughly flat from $1.8 billion in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $1.8 billion in Q4 2024, with the low at $5000.0 in Q3 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $1.3 billion across 4 years, with a median of $1.5 billion in 2023.
- The largest YoY upside for Shares Outstanding (Weighted Average) was 29438982.1% in 2024 against a maximum downside of 0.2% in 2024.
- Trans American Aquaculture's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then grew by 12.15% to $1.5 billion in 2023, then gained by 24.36% to $1.8 billion in 2024, then changed by 0.0% to $1.8 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.8 billion (Q3 2025), $1.8 billion (Q2 2025), and $1.8 billion (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Trans American Aquaculture | - | - | - | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | 1.81 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.81 Bn |
| Sep 30, 2024 | 1.47 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.45 Bn |
| Dec 31, 2023 | 1.45 Bn |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 1.45 Bn |
| Dec 31, 2022 | 1.29 Bn |